LSE - Delayed Quote GBp

Eden Research plc (EDEN.L)

3.8000
0.0000
(0.00%)
At close: June 6 at 4:01:04 PM GMT+1
Loading Chart for EDEN.L
  • Previous Close 3.8000
  • Open 3.8000
  • Bid --
  • Ask --
  • Day's Range 3.8000 - 4.0000
  • 52 Week Range 2.2330 - 4.8000
  • Volume 98,482
  • Avg. Volume 459,608
  • Market Cap (intraday) 20.267M
  • Beta (5Y Monthly) 1.25
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date May 6, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 20.00

Eden Research plc, together with its subsidiaries, engages in the development and sale of biopesticides in Europe and the United Kingdom. The company offers foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatments under the Mevalone and Cedroz brands for crop protection applications. It also provides consume products, such as head-lice treatment, deodorants, odour neutralizer, and fragrances, as well as food flavourings and active ingredients; and animal health products comprising companion animal, bio-control, parasite treatments, and insect sprays. Eden Research plc was incorporated in 1995 and is headquartered in Abingdon, the United Kingdom.

www.edenresearch.com

23

Full Time Employees

December 31

Fiscal Year Ends

Recent News: EDEN.L

View More

Performance Overview: EDEN.L

Trailing total returns as of 6/6/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

EDEN.L
3.80%
FTSE 100 (^FTSE)
8.14%

1-Year Return

EDEN.L
11.63%
FTSE 100 (^FTSE)
6.67%

3-Year Return

EDEN.L
12.64%
FTSE 100 (^FTSE)
16.16%

5-Year Return

EDEN.L
52.50%
FTSE 100 (^FTSE)
36.30%

Compare To: EDEN.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EDEN.L

View More

Valuation Measures

Annual
As of 6/6/2025
  • Market Cap

    20.27M

  • Enterprise Value

    16.76M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.71

  • Price/Book (mrq)

    1.72

  • Enterprise Value/Revenue

    3.90

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -44.31%

  • Return on Assets (ttm)

    -8.54%

  • Return on Equity (ttm)

    -15.07%

  • Revenue (ttm)

    4.3M

  • Net Income Avi to Common (ttm)

    -1.91M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.67M

  • Total Debt/Equity (mrq)

    1.42%

  • Levered Free Cash Flow (ttm)

    -3.07M

Research Analysis: EDEN.L

View More

Company Insights: EDEN.L

Research Reports: EDEN.L

View More

People Also Watch